A detailed history of Cambridge Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Cambridge Trust CO holds 3,427 shares of AMGN stock, worth $1.08 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,427
Previous 3,770 9.1%
Holding current value
$1.08 Million
Previous $1.09 Million 10.23%
% of portfolio
0.04%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 30, 2024

SELL
$268.87 - $324.56 $92,222 - $111,324
-343 Reduced 9.1%
3,427 $974,000
Q4 2023

Jan 31, 2024

SELL
$255.7 - $288.46 $130,662 - $147,403
-511 Reduced 11.94%
3,770 $1.09 Million
Q3 2023

Oct 26, 2023

BUY
$218.65 - $271.46 $64,283 - $79,809
294 Added 7.37%
4,281 $1.15 Million
Q2 2023

Jul 25, 2023

BUY
$214.27 - $253.37 $428 - $506
2 Added 0.05%
3,987 $885,000
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $7,676 - $9,356
34 Added 0.86%
3,985 $963,000
Q4 2022

Jan 09, 2023

BUY
$229.03 - $291.01 $19,696 - $25,026
86 Added 2.23%
3,951 $1.04 Million
Q3 2022

Nov 07, 2022

SELL
$224.46 - $253.15 $6,060 - $6,835
-27 Reduced 0.69%
3,865 $871,000
Q2 2022

Aug 16, 2022

SELL
$230.71 - $256.74 $108,202 - $120,411
-469 Reduced 10.75%
3,892 $947,000
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $173,881 - $192,358
-793 Reduced 15.39%
4,361 $1.05 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $188,339 - $215,537
947 Added 22.51%
5,154 $1.16 Million
Q3 2021

Nov 23, 2021

BUY
$212.27 - $248.7 $360,222 - $422,043
1,697 Added 67.61%
4,207 $895,000
Q3 2021

Nov 16, 2021

SELL
$212.27 - $248.7 $348,547 - $408,365
-1,642 Reduced 39.55%
2,510 $534,000
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $31,533 - $34,983
-135 Reduced 3.15%
4,152 $1.01 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $454,693 - $529,871
2,049 Added 91.55%
4,287 $1.07 Million
Q4 2020

Jan 27, 2021

SELL
$216.38 - $257.67 $25,965 - $30,920
-120 Reduced 5.09%
2,238 $514,000
Q3 2020

Nov 03, 2020

SELL
$234.65 - $260.95 $78,842 - $87,679
-336 Reduced 12.47%
2,358 $600,000
Q2 2020

Aug 05, 2020

SELL
$197.81 - $242.74 $33,034 - $40,537
-167 Reduced 5.84%
2,694 $656,000
Q1 2020

May 04, 2020

SELL
$182.24 - $241.7 $20,228 - $26,828
-111 Reduced 3.73%
2,861 $580,000
Q4 2019

Feb 04, 2020

BUY
$189.21 - $243.2 $49,573 - $63,718
262 Added 9.67%
2,972 $716,000
Q3 2019

Nov 06, 2019

BUY
$174.11 - $208.62 $39,174 - $46,939
225 Added 9.05%
2,710 $524,000
Q2 2019

Jul 29, 2019

BUY
$166.7 - $195.41 $26,005 - $30,483
156 Added 6.7%
2,485 $0
Q1 2019

Apr 22, 2019

SELL
$180.87 - $203.88 $120,097 - $135,376
-664 Reduced 22.19%
2,329 $442,000
Q4 2018

Feb 04, 2019

SELL
$178.4 - $208.25 $92,946 - $108,498
-521 Reduced 14.83%
2,993 $583,000
Q3 2018

Oct 22, 2018

SELL
$185.29 - $208.89 $7,782 - $8,773
-42 Reduced 1.18%
3,514 $729,000
Q2 2018

Aug 06, 2018

SELL
$166.05 - $186.51 $27,066 - $30,401
-163 Reduced 4.38%
3,556 $656,000
Q1 2018

Apr 27, 2018

SELL
$169.43 - $198.0 $59,639 - $69,696
-352 Reduced 8.65%
3,719 $634,000
Q4 2017

Jan 24, 2018

BUY
$168.79 - $188.59 $24,980 - $27,911
148 Added 3.77%
4,071 $0
Q3 2017

Nov 02, 2017

BUY
$167.29 - $191.0 $656,278 - $749,293
3,923
3,923 $0

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.